PRESS DIGEST-New York Times business news - October 29

By Reuters News

- The following are the top stories on the New York Times business pages. Reuters has not verified these stories and does not vouch for their accuracy.

- Weil, Gotshal & Manges is preparing to wind down its operations, capping a dizzying downfall for the nearly century-old Wall Street law firm after it failed to stem an exodus of partners.

- US District Judge David Carter rejected a request by the Justice Department to temporarily block California from counting mail ballots for the midterm elections from more than 20,000 registered voters the department alleges are likely noncitizens.

- US Health Secretary Robert F. Kennedy Jr. pushed forward a policy allowing licensed pharmacies and physicians to compound certain unapproved peptides while regulators consider whether to formally permit their use in compounded medicines.

- The Trump administration banned imports from Chinese genomics company BGI and its subsidiaries over their alleged roles in enabling the forced labor of Uyghurs and other ethnic minorities in China's Xinjiang region.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.